Mind Map: Goitre Approach
Initial Assessment
Start with serum TSH measurement in all patients with goitre—this single test determines your entire diagnostic and management pathway 1, 2, 3.
Clinical Evaluation
- Compressive symptoms: dysphagia, dyspnea, choking sensation, cough
- Thyroid dysfunction symptoms: hyperthyroidism vs hypothyroidism
- Risk factors: family history, radiation exposure, iodine deficiency, rapid growth
- Physical examination: goitre size, consistency, mobility, cervical lymphadenopathy, tracheal deviation
Diagnostic Algorithm
1. TSH-Directed Pathway
If TSH is LOW → Proceed to thyroid scintigraphy (Na[99mTc]TcO4 or Na[123I]I) 4, 2
- Identifies hyperfunctioning (hot) nodules
- Maps cold nodules requiring biopsy
- Evaluates radiotracer distribution heterogeneity
If TSH is NORMAL or HIGH → Proceed directly to ultrasound evaluation 2, 3
2. Thyroid Ultrasound (Mandatory for All Patients)
Ultrasound has become an extension of physical examination and should be performed in all patients with goitre 1, 2, 3.
Evaluate:
- Number, size, and location of nodules
- Echogenic features (TI-RADS classification for malignancy risk stratification) 5
- Comet-tail artifacts (suggests benign colloid goitre) 6
- Vascular mapping on color Doppler
- Substernal extension
- Relationship to trachea and esophagus
3. Fine Needle Aspiration (FNA)
Perform US-guided FNA on nodules selected based on:
- Suspicious ultrasound features per TI-RADS classification 4, 5
- Dominant nodules in multinodular goitre
- Cold nodules on scintigraphy (if performed) 4
Do NOT biopsy:
- Scintigraphically hot/autonomous nodules 4
- Multiple small benign-appearing nodules without suspicious features
4. Cross-Sectional Imaging (CT/MRI)
CT and MRI are NOT routinely required for initial workup 1.
Use CT or MRI selectively for 1, 4:
- Substernal/retrosternal goitre extension
- Evaluation of tracheal compression or stenosis
- Assessment of esophageal compression/invasion
- Preoperative vascular anatomy mapping
- Intrathoracic multinodular goitre
- Lymph node mapping when malignancy suspected
Technical considerations:
- CT without contrast is usually sufficient 4
- Use contrast-enhanced CT for suspected malignancy or vascular assessment 1
- MRI preferred if TSH is low (avoids iodine load) and provides better soft tissue resolution 1
- Use same imaging modality for pre- and post-treatment comparison 4
Management Pathways
Cytology Results Direct Treatment
MALIGNANT cytology → Surgery 3
SUSPICIOUS/INDETERMINATE cytology → Surgery (unless autonomous function confirmed on scintigraphy) 3
BENIGN cytology → Stratify by symptoms and size
Treatment Options by Clinical Scenario
A. Asymptomatic Euthyroid Benign Goitre
Observation is appropriate 4, 3
B. Symptomatic Benign Goitre (Compressive Symptoms)
Surgery is the primary option for:
- Large goitres with dysphagia, dyspnea, or airway obstruction 3
- Fast resolution of tracheal compression required 4
- Substernal goitre causing symptoms 4
Radioactive iodine (RAI) therapy indicated for 4:
- Thyroid volume <100 ml with compressive symptoms
- Elderly patients and/or significant comorbidities (especially cardiovascular)
- Previous neck surgery history
- Large goitre with intrathoracic extension when surgery refused/contraindicated
- Requires 24-hour RAIU ≥15% (can use rhTSH if lower)
RAI absolute contraindications 4:
- Pregnancy or lactation
- Suspected/confirmed thyroid cancer
- Need for rapid decompression
RAI relative contraindications 4:
- 24-hour RAIU <15%
- Thyroid volume >100 ml
- Symptomatic nodule is scintigraphically cold
C. Toxic Nodular Goitre/Autonomous Nodules
Definitive therapy options 7:
- Surgery
- Radioactive iodine (I-131)
- Percutaneous ethanol injection (PEI) for selected toxic autonomous functioning thyroid adenomas
Thionamides (carbimazole/propylthiouracil): Control hyperthyroidism temporarily before definitive therapy, not for long-term use 2, 7
D. Medical Management (Limited Role)
- May reduce goitre size in some euthyroid patients
- Requires continued therapy to prevent regrowth
- Not first-line for most patients
Iodine supplementation 4:
- Prevention strategy in iodine-deficient areas
- Limited efficacy for established goitre
- Associated with increased Hashimoto's thyroiditis and papillary thyroid carcinoma risk
Critical Pitfalls to Avoid
- Do not perform FNA on hot nodules—they are almost never malignant 4
- Do not order routine CT/MRI—reserve for specific indications to avoid unnecessary radiation and cost 1
- Do not assume all nodules in multinodular goitre are benign—5% harbor malignancy 3
- Do not use CT with iodinated contrast if RAI therapy planned—delays treatment 1
- Do not treat asymptomatic benign goitre routinely—observation is safe 4, 5